GILEAD SCIENCES INC's ticker is and the CUSIP is 375558903. A total of 15 filers reported holding GILEAD SCIENCES INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $114,819,000 | +4.2% | 1,376,400 | +14.7% | 0.13% | -7.9% |
| Q1 2016 | $110,186,000 | +49.8% | 1,199,500 | +65.0% | 0.14% | +73.8% |
| Q4 2015 | $73,575,000 | -21.2% | 727,100 | -23.6% | 0.08% | -10.1% |
| Q3 2015 | $93,408,000 | -5.7% | 951,300 | +12.5% | 0.09% | +3.5% |
| Q2 2015 | $99,026,000 | +234.8% | 845,800 | +180.6% | 0.09% | +207.1% |
| Q1 2015 | $29,576,000 | -32.9% | 301,400 | -35.6% | 0.03% | -34.9% |
| Q4 2014 | $44,085,000 | -39.3% | 467,700 | -31.5% | 0.04% | -43.4% |
| Q3 2014 | $72,684,000 | +41.7% | 682,800 | +10.4% | 0.08% | +28.8% |
| Q2 2014 | $51,280,000 | -14.2% | 618,500 | -26.6% | 0.06% | -15.7% |
| Q1 2014 | $59,735,000 | +24.0% | 843,000 | +31.5% | 0.07% | +11.1% |
| Q4 2013 | $48,179,000 | +14.8% | 641,100 | -4.0% | 0.06% | -1.6% |
| Q3 2013 | $41,952,000 | +64.2% | 667,600 | +33.8% | 0.06% | +45.5% |
| Q2 2013 | $25,554,000 | – | 499,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFM Health Sciences, LP | 963,700 | $67,314,000 | 1.98% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $10,478,000 | 0.32% |
| Capital Markets Trading UK LLP | 245,200 | $17,394,000 | 0.23% |
| GROUP ONE TRADING, L.P. | 1,338,800 | $93,515,000 | 0.10% |
| SIMPLEX TRADING, LLC | 757,000 | $52,331,000 | 0.05% |
| Marathon Trading Investment Management LLC | 4,000 | $279,000 | 0.02% |
| Maven Securities LTD | 5,400 | $377,000 | 0.01% |
| Allianz Asset Management GmbH | 70,900 | $4,952,000 | 0.00% |
| JPMORGAN CHASE & CO | 155,900 | $10,890,000 | 0.00% |
| CIBC WORLD MARKETS CORP | 2,000 | $140,000 | 0.00% |